Cargando…

Differential RNA Expression Profile of Skeletal Muscle Induced by Experimental Autoimmune Myasthenia Gravis in Rats

The differential susceptibility of skeletal muscle by myasthenia gravis (MG) is not well understood. We utilized RNA expression profiling of extraocular muscle (EOM), diaphragm (DIA), and extensor digitorum (EDL) of rats with experimental autoimmune MG (EAMG) to evaluate the hypothesis that muscles...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaminski, Henry J., Himuro, Keiichi, Alshaikh, Jumana, Gong, Bendi, Cheng, Georgiana, Kusner, Linda L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102901/ https://www.ncbi.nlm.nih.gov/pubmed/27891095 http://dx.doi.org/10.3389/fphys.2016.00524

Ejemplares similares

Editorial: Advances in Autoimmune Myasthenia Gravis
por: Punga, Anna Rostedt, et al.
Publicado: (2020)

Serum Metabolomic Response of Myasthenia Gravis Patients to Chronic Prednisone Treatment
por: Sengupta, Manjistha, et al.
Publicado: (2014)

Serum metabolomics of treatment response in myasthenia gravis
por: Sikorski, Patricia, et al.
Publicado: (2023)

Changes in inflammatory cytokine networks in myasthenia gravis
por: Uzawa, Akiyuki, et al.
Publicado: (2016)

MicroRNA and mRNA expression associated with ectopic germinal centers in thymus of myasthenia gravis
por: Sengupta, Manjistha, et al.
Publicado: (2018)

The Role of Osteopontin and Its Gene on Glucocorticoid Response in Myasthenia Gravis
por: Xie, Yanchen, et al.
Publicado: (2017)

Role of miRNAs in Normal and Myasthenia Gravis Thymus
por: Cron, Mélanie A., et al.
Publicado: (2020)

Survivin as a Potential Mediator to Support Autoreactive Cell Survival in Myasthenia Gravis: A Human and Animal Model Study
por: Kusner, Linda L., et al.
Publicado: (2014)

Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors — Recommendations for methods and experimental designs
por: Losen, Mario, et al.
Publicado: (2015)

Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis
Publicado: (1978)

Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies
Publicado: (1976)

Autoimmune Thyroiditis and Myasthenia Gravis
por: Lopomo, Angela, et al.
Publicado: (2017)

Inflammation and autoimmune myasthenia gravis
por: Huda, Ruksana
Publicado: (2023)

Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs
Publicado: (1975)

Corticosteroid Treatment-Resistance in Myasthenia Gravis
por: Kaminski, Henry J., et al.
Publicado: (2022)

Prophylactic Effect of Probiotics on the Development of Experimental Autoimmune Myasthenia Gravis
por: Chae, Chang-Suk, et al.
Publicado: (2012)

Complement Inhibitor Therapy for Myasthenia Gravis
por: Albazli, Khaled, et al.
Publicado: (2020)

Investigational RNAi Therapeutic Targeting C5 Is Efficacious in Pre-clinical Models of Myasthenia Gravis
por: Kusner, Linda L., et al.
Publicado: (2019)

Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study
por: McPherson, Tarrant, et al.
Publicado: (2020)

Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis
Publicado: (1976)

Autoimmune myasthenia gravis after COVID-19 in a triple vaccinated patient
por: Croitoru, Cristina-Georgiana, et al.
Publicado: (2022)

Experimental autoimmune myasthenia gravis and CD5+ B-lymphocyte expression.
por: Lee, K. W., et al.
Publicado: (1999)

CD59 Expression in Skeletal Muscles and Its Role in Myasthenia Gravis
por: Iwasa, Kazuo, et al.
Publicado: (2022)

Monoclonal Antibody-Based Therapies for Myasthenia Gravis
por: Alabbad, Sawsan, et al.
Publicado: (2020)

Autoimmune myasthenia gravis and COVID-19. A case report-based review
por: Croitoru, Cristina Georgiana, et al.
Publicado: (2023)

Autoimmune Myasthenia Gravis after Sternal Fracture
por: Petersen, Jens A., et al.
Publicado: (2012)

Therapeutic Effect of Bifidobacterium Administration on Experimental Autoimmune Myasthenia Gravis in Lewis Rats
por: Rinaldi, Elena, et al.
Publicado: (2019)

Muscle-Specific Kinase Myasthenia Gravis
por: Borges, Lucia S., et al.
Publicado: (2020)

Extraocular Muscle Atrophy in Myasthenia Gravis
por: Pedapati, Radhakrishna, et al.
Publicado: (2022)

AEB-071 Ameliorates Muscle Weakness by Altering Helper T Lymphocytes in an Experimental Autoimmune Myasthenia Gravis Rat Model
por: Jing, Feng, et al.
Publicado: (2020)

B-Cell-Activating Factor and Autoimmune Myasthenia Gravis
por: Ragheb, Samia, et al.
Publicado: (2011)

Complicating autoimmune diseases in myasthenia gravis: a review
por: Nacu, Aliona, et al.
Publicado: (2015)

New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis
por: Behin, Anthony, et al.
Publicado: (2018)

Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.
por: Pachner, A. R.
Publicado: (1987)

Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysis
por: Harris, Linda, et al.
Publicado: (2019)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Myasthenia Gravis
Publicado: (1905)

Myasthenia Gravis
por: Wilson, Andrew
Publicado: (1952)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

Cannot write session to /tmp/vufind_sessions/sess_jiqiv810i172imqe3272pbu3ed